300+ investors in your industry, stage, and region Get
Any industry
Big Data
Video Games
Clean Energy
Google
Construction
Hospitality
EdTech
Consumer
Artificial Intelligence
Local
Enterprise Software
Platforms
Travel
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
Film
Payments
Photography
Email
CleanTech
Energy
Marketplace
SaaS
Restaurants
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Education
Wellness
Medical Device
Mobile
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Theatre
Crowdfunding
Recruiting
Web3
Medical
Infrastructure
Beauty
Fashion
Venture Capital
Social
LGBT
Cannabis
Climate
Celebrity
Wine and Spirits
Food and Beverage
Publishing
Life Science
Mobile Apps
Music
Real Estate
Sporting Goods
Art
Digital Media
FinTech
Manufacturing
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Biotech
Sustainability
Transportation
Proptech
Impact
Hardware
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
United Kingdom
Hong Kong
Thailand
United Arab Emirates
Greece
Benin
Croatia
Japan
South Korea
Burkina Faso
Africa
Brazil
Singapore
Oceania
LATAM
Gibraltar
Egypt
Kyrgyzstan
Zambia
Zimbabwe
Sweden
Taiwan
Norway
Tajikistan
Tunisia
Liberia
Malawi
Mexico
Nigeria
Russian Federation
Togo
Nepal
Guinea
Haiti
Iran
Isle of Man
Lesotho
Madagascar
Pakistan
Romania
Puerto Rico
Oman
Poland
Guernsey
Cameroon
Andorra
Colombia
Sudan
Costa Rica
China
Armenia
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Paraguay
Seychelles
Botswana
Canada
South Africa
France
Georgia
Denmark
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
Senegal
El Salvador
Tanzania
India
Germany
Ireland
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Qatar
Spain
Angola
Europe
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Ecuador
Estonia
Faroe Islands
Jersey
Bahrain
Bahamas
Bolivia
Belize
Algeria
Italy
Finland
Belarus
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Biotechnology Angel Investors in Switzerland (September 2026)

The most active angel investors investing in Switzerland Biotechnology startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Switzerland Biotechnology startup companies. Find investors to raise a Pre-Seed, Seed or Series A round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Penny Schiffer
Angel
4 Switzerland, Germany, United Kingdom Seed, Series A, Series B Medical, Software, Health Care $495k–$8M
Andrew Keys
Angel
3 United States, India, Norway Seed, Pre-Seed, Series A Software, Finance, Blockchain $1M–$34M
Harry Welten
Angel
2 Switzerland Series A Biotechnology, Medical, Health Care $1.3M–$38M
Daniel Gutenberg
Angel
2 Switzerland, United States, Israel Seed, Series A, Pre-Seed Software, Artificial Intelligence, SaaS $1.1M–$18M
Thomas Zehnder
Angel
1 Switzerland Seed Health Care, Life Science, Biotechnology
Mark Nelson
Angel
1 Switzerland, United States Seed, Pre-Seed, Series A Artificial Intelligence, B2B, CRM
Ted Kummert
Angel
1 Switzerland, United States Seed, Series A CRM, Big Data, Software
Alexsis de Raadt-St. James
Angel
1 United States, Switzerland, United Kingdom Seed, Series A, Series B Software, SaaS, Health Care $250k–$24M
Chris Gibson
Angel
1 United States, France, Switzerland Series A, Seed Biotechnology, Health Care, Life Science $4.9M–$55M
Igor Fish
Angel
1 Switzerland Series A Medical, Health Care, Life Science
Anders Indset
Angel
1 Switzerland Venture - Series Unknown Computer, Security, Life Science
Alejo Costa Ribalta
Angel
1 Spain, Germany, Switzerland Venture - Series Unknown, Series A Health Care, Fitness, Apps $4.3M–$7.5M
Arda Kara
Angel
1 United States, Germany, Switzerland Series A, Seed, Series B Health Care, Medical, Software $25M–$38M
Konstantin Othmer
Angel
1 United States, Latvia, Germany Seed, Pre-Seed Automotive, Health Care, SaaS $520k–$18M
Balaji Srinivasan
Angel
1 United States, India, Singapore Seed, Pre-Seed, Series A Blockchain, Cryptocurrency, Software $650k–$28M
Helmut Deschauer
Angel
1 Switzerland Pre-Seed Genetics, Oncology, Generative AI $1.5M–$1.9M
Tej Tadi
Angel
1 Switzerland Seed Robotics, Neuroscience
Peter Herger
Angel
1 Switzerland Pre-Seed Wellness, Neuroscience, Information Technology
Ian Metcalfe
Angel
1 Switzerland Pre-Seed Biotechnology
Zürcher Kantonalbankand
Angel
1 Switzerland Seed, Series A, Series B Medical Device, Energy, Leasing $1.1M–$4.4M
Ronjon Nag
Angel
1 United Kingdom, United States, Canada Seed, Pre-Seed, Series B Artificial Intelligence, Software, Health Care $472k–$13M
Katelyn Donnelly
Angel
1 United States, Germany Seed, Pre-Seed, Series A Artificial Intelligence, Software, Education $600k–$13M
Ulf Claesson
Angel
1 Switzerland Seed Biotechnology, Food and Beverage
Philip Wels
Angel
1 Switzerland Pre-Seed, Seed Information Technology, Sports, Software
Feike Sijbesma
Angel
1 Switzerland, United Kingdom Seed, Series B Biotechnology, Bioinformatics, Pharmaceutical
Piero Novelli
Angel
1 Switzerland Pre-Seed Wellness, Neuroscience, Information Technology
Urs Berger
Angel
1 Switzerland Pre-Seed Wellness, Neuroscience, Information Technology
John Zimmer
Angel
1 United States, Denmark, Switzerland Seed, Series B Mining, FinTech, Mineral $5M–$193M
Thorsten Schroeder
Angel
1 United States, Brazil, Mexico Seed, Series B, Venture - Series Unknown Children, E-Commerce, Electronics $4M–$23M
Walter Fischl
Angel
1 Switzerland Venture - Series Unknown Medical, Health Care, Biotechnology
Nitin Sharma
Angel
1 India, United States, Germany Pre-Seed, Seed, Grant Financial Services, Software, Information Technology $165k–$11M
Young Sohn
Angel
1 United States, Germany, Switzerland Seed, Series A, Series B Software, Artificial Intelligence, SaaS $200k–$110M
Kirill Eves
Angel
1 India, Switzerland, United Arab Emirates Seed, Pre-Seed B2B, Gaming, Medical $3M–$18M
Edward Ludwig
Angel
1 Switzerland, United States Seed, Series A, Corporate Round Medical, Biotechnology, Health Care
Qiao Wang
Angel
1 United States, Singapore, China Seed, Pre-Seed, Venture - Series Unknown Blockchain, Software, Cryptocurrency $350k–$12M
Christopher Gibson
Angel
1 United States, United Kingdom, France Series A, Seed, Series B Biotechnology, Health Care, Pharmaceutical $1.5M–$55M
Marc Maurer
Angel
1 Switzerland Series A Artificial Intelligence, Software, Machine Learning $16M–$18M
Emily Leproust
Angel
1 United States, Switzerland Seed Biotechnology, Health Care, Product Research $1.5M–$5.7M
Patrick Delarive
Angel
1 Switzerland Seed Security, Wireless, Wearables
Reinhard Ambros
Angel
1 United States, Switzerland Series A, Series B, Series C Biotechnology, Health Care, Biopharma
Nicolas Weber
Angel
1 Switzerland, United Kingdom Seed, Pre-Seed Genetics, Oncology, Health Care
Thomas Glocer
Angel
1 United States, United Kingdom, Israel Seed, Series A, Series C Software, FinTech, Analytics $1M–$75M
Lukas Speiser
Angel
1 Switzerland, Germany Seed, Pre-Seed Health Care, SaaS, Retail $161k–$3M
Tobias Reichmuth
Angel
1 Switzerland Seed, Angel, Pre-Seed E-Commerce, Travel, Internet $138k–$2.6M
Beat Schillig
Angel
1 Switzerland Seed, Series A Information Technology, SaaS, Music $2M–$4.8M
Christoph Behn
Angel
1 Germany, Switzerland Pre-Seed, Seed, Venture - Series Unknown Software, Manufacturing, Advanced Materials $1.1M–$6.9M
Marcello Campanelli
Angel
1 Switzerland Pre-Seed Biotechnology
Miklos Stanek
Angel
1 Switzerland Seed, Pre-Seed, Series A Health Care, Biotechnology, Pharmaceutical $5.1M–$7.7M
Mathias Maurer
Angel
1 Switzerland Seed, Pre-Seed Wellness, Neuroscience, Information Technology
Delia Schrafl
Angel
1 Switzerland Pre-Seed Wellness, Neuroscience, Information Technology
Access all 49 angel investors in Switzerland Biotechnology startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Penny Schiffer
Angel · 4 investments in Switzerland Biotechnology startups

Penny Schiffer - CEO & Co-founder @ Raized.ai

Show more...

Investment focus

  • Industry: Medical, Software, Health Care
  • Stage:Seed, Series A, Series B
  • Geography: Switzerland, Germany, United Kingdom

Investor stats

  • Total investments: 34
  • Round size: Seed $495k–$8M; Series A $1.2M–$6M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Versameb — Versameb AG is a preclinical-stage biopharmaceutical company located in Basel, Switzerland managed by an experienced scientific and business pharmaceutical industry team. The company’s focus is the development of novel RNA-based therapeutics. Versameb’s proprietary VERSagile technology platform enables efficient development of functional mRNAmolecules for customized protein expression and modification in multiple disease areas with high unmet medical need.
  • Enterprise Bot — Cost-effective Conversational AI solutions transforming customer interaction for global enterprises. Discover cutting-edge chat, email, and voice tech.
  • Scientific Visual — Scientific Visual supplies quality control workstations to visualize defects in non-polished sapphire such as watch covers, ingots and wafers.
Show all investments...

Andrew Keys
Angel · 3 investments in Switzerland Biotechnology startups

Andrew Keys is the Co-Founder and Managing Partner of Andrew Keys. He previously worked for ConsenSys as a Head of Global Business Development. Andrew Keys attended Loyola University Maryland.

Show more...

Investment focus

  • Industry: Software, Finance, Blockchain
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, India, Norway

Investor stats

  • Total investments: 14
  • Round size: Seed $1M–$34M; Pre-Seed $1.4M–$2.5M; Series A $14M–$15M
  • Lead/follow: 7% lead, 93% follow

Portfolio highlights

  • Stackr Labs — Micro-rollups to scale web3 applications
  • Zivoe Finance — Join Zivoe in disrupting predatory high-interest lending.
  • Ithaca Finance — Ithaca Finance a cross-chain derivatives trading and settlements protocol, is composed of an on-chain settlement layer with an innovative off-chain matching engine.
Show all investments...

Harry Welten
Angel · 2 investments in Switzerland Biotechnology startups

Harry has 20 years of international executive experience, more than 11 of which as a CFO in the biotech industry. Prior to joining Cytos, Mr. Welten was CFO at Nitec Pharma AG in Reinach, Switzerland, which merged with US-based Horizon Pharma Inc. and was listed on Nasdaq in 2011. From 2001 to 2009, he was CFO at Arpida AG, Basel, Switzerland,taking the company public in 2005 to the SIX Swiss Exchange and raising more than CHF 250 million in private and public offerings. Prior to joining Arpida, he held various senior management positions at UBS group including Director at UBS Warburg in New York. Before joining UBS, Mr. Welten was with ABB and DaimlerChrysler. He is a member of the Board of Directors of BiognoSYS AG, Horizon Pharma AG, and BioSupport AG, and a member of the foundation council of HBM Foundation. He holds a degree in banking and finance, a degree in economics and business administration and an MBA (Hons) from Columbia University, NY, USA.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Series A
  • Geography: Switzerland

Investor stats

  • Total investments: 2
  • Round size: Series A $1.3M–$38M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Anokion — Anokion, a spin-off from the Ecole Polytechnique Fédérale de Lausanne (EPFL), is focused on applying the company’s antigen-specific immune tolerance technology to reduce the immunogenicity of therapeutic proteins and to treat autoimmune and allergic diseases. As a platform technology, Anokion’s approach to antigen-specific tolerance can betranslated to virtually any protein in numerous clinical indications.
  • Virometix — Virometix is a privately held biotechnology company developing a new generation of vaccines and immunotherapeutic drugs for the prevention and treatment of infectious and chronic human diseases.In an increasingly global world there is a considerable medical need for vaccines to combat infectious as well as a number of chronic human diseases. Fastgrowing demands, health threats from newly arising complex viral and bacterial pathogens and increasingly stringent requirements for stability, safety and tolerability require new approaches to tackling current and future challenges.Rational molecular design, chemical synthesis and Virometix' proprietary Synthetic Virus-Like Particle platform technology allow for the rapid production and optimization of vaccine candidates with superior properties in terms of safety, efficacy and stability.
Show all investments...

Daniel Gutenberg
Angel · Zürich, Zurich, Switzerland · 2 investments in Switzerland Biotechnology startups

Daniel joined VI Partners in July 2003 as a Venture Partner focusing on IT. He started his career as Chairman and CEO of Gutenberg Communication Systems AG, a company he founded in 1991. Subsequent to selling Gutenberg Communication Systems AG to the Telindus Group in 2000, he became Country Manager of Telindus for Switzerland, Austria andHungary during the next two years, and he was also a member of the Executive Board. Since 2002 he has been taking consulting and advisory board assignments for various companies.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, SaaS
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Switzerland, United States, Israel

Investor stats

  • Total investments: 28
  • Round size: Seed $1.4M–$18M; Pre-Seed $1.1M–$2M; Series A $3M–$18M
  • Lead/follow: 11% lead, 89% follow

Portfolio highlights

  • fonio.ai — Founded in Vienna in 2024, fonio.ai provides AI-powered phone assistants that automate customer communication 24/7. The platform answers calls, forwards inquiries, books appointments, and integrates with CRM and ERP systems, while every interaction is transcribed and can be stored, shared, or connected to existing tools.
  • aeon.life — Preventive healthcare platform that equips people with personalized insights and expert guidance for proactive whole-body health
  • NextBusiness — NextBusiness makes tools for founders in Switzerland. We build the AI-first business software infinity.swiss.
Show all investments...

Thomas Zehnder
Angel · Zürich, Zurich, Switzerland · 1 investments in Switzerland Biotechnology startups

Thomas Zehnder - Partner @ BlueOcean Ventures

Show more...

Investment focus

  • Industry: Health Care, Life Science, Biotechnology
  • Stage:Seed
  • Geography: Switzerland

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Testmate Health — 2 in 1 urine test with immediate results for Chlamydia trachomatis and Neisseria gonorrhoeae. Results within minutes & 100% anonymous.
Show all investments...

Mark Nelson
Angel · 1 investments in Switzerland Biotechnology startups

Investment focus

  • Industry: Artificial Intelligence, B2B, CRM
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Switzerland, United States

Investor stats

  • Total investments: 3
  • Lead/follow: 67% lead, 33% follow

Portfolio highlights

  • Veezoo — Veezoo empowers individuals to find actionable insights from data by literally just asking questions in plain English!
  • Ridge AI — Ridge AI makes it fast and easy for SaaS companies to prove value inside their product.
  • Golden Analytics — Golden is an AI-native BI platform that makes data easy, powerful & beautiful.
Show all investments...

Ted Kummert
Angel · Seattle, Washington, United States · 1 investments in Switzerland Biotechnology startups

Ted joined Madrona in 2013 and brings his years of technical and operational leadership in enterprise technology to Madrona and the portfolio companies. As Venture Partner, Ted identifies new investments and provides strategic counsel and operational advice to Madrona portfolio companies. Prior to Madrona, Ted drove major product and businessinitiatives for Microsoft for more than two decades. At Microsoft, Kummert led teams across a broad set of technologies, including operating systems, consumer online services, enterprise security and enterprise application platform. As Corporate Vice President of the Data Platform Group, Kummert led the development of several key Microsoft enterprise products including SQL Server, SQL Server Parallel Data Warehouse, Windows Azure Data Services and Microsoft's business intelligence and big data offerings. Widely known as the "data chief" of Microsoft, he led the data platform business through a period of significant growth and drove the cloud and big data strategy for the platform. Ted began his career at Apple and HP.

Show more...

Investment focus

  • Industry: CRM, Big Data, Software
  • Stage:Seed, Series A
  • Geography: Switzerland, United States

Investor stats

  • Total investments: 2
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • Veezoo — Veezoo empowers individuals to find actionable insights from data by literally just asking questions in plain English!
  • Tektonic AI — Tektonic unlocks new, previously impossible automation use cases from sales and revenue processes to broader business operations.
Show all investments...

Alexsis de Raadt-St. James
Angel · San Francisco, California, United States · 1 investments in Switzerland Biotechnology startups

Alexsis is the Founder and Managing Partner of Merian Ventures, an early-stage venture firm focused on investing in women founded, co-founded and majority-owned companies in the US and UK. Alexsis has extensive investment, venture and operations experience based on businesses she has founded or funded. As managing partner of Merian Ventures since2015, Alexsis serves as a Board Member and Advisor to Merian Venture portfolio companies Provenance, Pivigo, Populus, Honeycomb, ImpactVision, CareerLark, Cirrus Identity and Compaas, among others. Merian Ventures was named after Maria Sibylla Merian, a botanist, entrepreneur and intrepid traveler born in 1647. In addition to Merian Ventures, Alexsis is a US-UK Fulbright Commissioner; Board member of the Oxford Internet Institute; Board member of The Oxford Foundry; Founder and funder of the WEInnovate STEM accelerator for Women at Imperial College, London; and Board Member and Advisor to companies she's funded. Alexsis is also Chairman and Founder of The Althea Foundation, established in 2003 as a family office. Today, The Althea Foundation is a California nonprofit public benefit corporation and it is recognized by the Internal Revenue Service as a public charity described in Internal Revenue Code Sections 501(c)(3) and 509(a)(1).

Show more...

Investment focus

  • Industry: Software, SaaS, Health Care
  • Stage:Seed, Series A, Series B
  • Geography: United States, Switzerland, United Kingdom

Investor stats

  • Total investments: 9
  • Round size: Seed $250k–$2.9M; Series A $2.1M–$24M
  • Lead/follow: 11% lead, 89% follow

Portfolio highlights

  • Aiden — Reduce risk, enhance compliance, and simplify IT with modern, intelligent software packaging and deployment using Artificial Intelligence.
  • Compaas — Compaas: The Compensation Platform | Total Visibility. Zero Spreadsheets. Painless raise cycles, compensation metrics, people analytics, rewards letters
  • Provenance — Provenance is a software solution for sustainability communications and supply chain transparency.
Show all investments...

Chris Gibson
Angel · Salt Lake City, Utah, United States · 1 investments in Switzerland Biotechnology startups

Chris Gibson is the Co-Founder and CEO of Recursion (Recursion Pharmaceuticals). He previously worked at Cure HHT as a Member Board of Directors. Chris Gibson attended the University of Utah.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Life Science
  • Stage:Series A, Seed
  • Geography: United States, France, Switzerland

Investor stats

  • Total investments: 10
  • Round size: Seed $4.9M–$14M; Series A $6.3M–$55M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Amenities Health — Amenities is the healthcare industry's leading Digital Front Door and patient loyalty platform. We help healthcare providers to acquire new patients and upgrade them to members. Our all-in-one patient app works with most modern EMRs to: 1) register new users into a full EMR account in <30 seconds with full identity verification and noduplicates, 2) help those patients find care options and book appointments with simple, conversion-optimized workflows, 3) seamlessly integrates key patient portal and 3rd party functions (i.e., video visits, secure messaging, test results, and billing), and 4) upgrade patients to members with custom experiences and services offerings (i.e., for Medicare Advantage, concierge memberships, direct-to-employer, or direct primary care patients)
  • Cradle — Using robust prediction algorithms and AI design recommendations, Cradle assists biologists in rapidly designing better proteins. Cradle gives you complete ownership of the intellectual property while maintaining the privacy and security of your sequences and data.
  • Leash Biosciences — We're transforming drug design with a rich dataset built by screening millions of compounds against thousands of protein to generate billions of data points, ideal for training advanced machine learning models.
Show all investments...

Igor Fish
Angel · Epalinges, Vaud, Switzerland · 1 investments in Switzerland Biotechnology startups

Igor Fish

Show more...

Investment focus

  • Industry: Medical, Health Care, Life Science
  • Stage:Series A
  • Geography: Switzerland

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • NewBiologix — NewBiologix operates as a technology innovation company, develops a proprietary and breakthroughDNA integration platform for the advanced engineering of human and mammaliancell lines.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Anders Indset
Angel · Frankfurt, Hessen, Germany · 1 investments in Switzerland Biotechnology startups

Anders Indset is the Founding Partner at GILT I Global Institute of Leadership & Technology.

Show more...

Investment focus

  • Industry: Computer, Security, Life Science
  • Stage:Venture - Series Unknown
  • Geography: Switzerland

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Terra Quantum — Terra Quantum offers Quantum as a Service in the areas of quantum algorithms, quantum computing and quantum security.
Show all investments...

Alejo Costa Ribalta
Angel · 1 investments in Switzerland Biotechnology startups

Alejo Costa Ribalta is a Partner at CRB Health Tech SGEIC.

Show more...

Investment focus

  • Industry: Health Care, Fitness, Apps
  • Stage:Venture - Series Unknown, Series A
  • Geography: Spain, Germany, Switzerland

Investor stats

  • Total investments: 4
  • Round size: Venture - Series Unknown $4.3M–$7.5M
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • Eholo — Eholo is the management tool for psychologists and clinics that helps you optimize your time and focus on what really matters: your patients.
  • LIOM — Pioneering in non-invasive glucose monitoring technology, seamlessly integrated with health metrics for a revolutionary wearable experience.
  • AssistMe — With a smart, adaptive and automated form of data processing and preparation, alea opens the way for future-proof, digitally supported everyday care. As an initial component of the AssistMe care platform, alea enables a contemporary, efficient care data culture for future intersectoral, networked processes and digitally supported teamwork. In theend, the aim is to effectively support care in times of a shortage of skilled workers through more self-determined content transparency - with complete personal autonomy and freedom of action and less redundancy & stress.Elderly Care will struggle in the next 10 years due to an increasing ageing population, fewer caregivers, more workload, stress, and manual documentation. All of that is a problem for the well-being of those in need of care. Furthermore, the incontinence management means large time and material expenses for caregivers. With the joint system, both companies can equip over 80 % of care recipients in care homes. An initial scientific study proved that the system could save 23 % of adult diapers and time while changing them. Together with significantly fewer leakages, the caregiver can reinvest the time gained in even higher quality care work. This ultimately has the potential to benefit care recipients in terms of quality of sleep and life. Digital functions for optimized care processesWith a very new smart sensor strip, we made leading quality adult diaper brands compatible with the digital possibilities of intelligent care technology of alea. The system reveals where care needs exist, but are not immediately visible, e.g. the urine status in the adult diaper which previously was not known until manually checked. The system transforms this initially hidden care and health data and converts it into digital, structured, immediately understandable real-time information for elderly care and its relevant stakeholders. All functionalities are based on the device alea sensor clip on smart Diaper products, which can be attached and changed in seconds. With just one quick click, caregivers turn the smart diaper into a ready-to-use digital care assistance system. With an optimal sensor position in the centre of the adult diaper and without direct skin contact. The alea hardware can generate highly valid information and make it available to care staff in real time through the mobile and web apps. The care-relevant information of alea includes the amount of urine, movements in the care bed for effective pressure ulcer prevention, fall detection and zone management. How caregivers, care homes & care recipients benefitOver 80 % of care home residents suffer from incontinence. This is a major challenge for everyone involved. The smart system solves issues for all care related audiences: Care recipients benefit from less time in full incontinence pads, but also benefit from fewer manual visual checks during bedtimes. In addition, there is a higher level of safety and prevention. By reducing time-consuming routine and visual checks on an as-needed basis. Caregivers can invest the time gained in other important or relevant care tasks. In this way, they can increase their self-determination in their work and thus their job satisfaction. Thanks to the significant savings in materials and costs, care home operators gain more planning security and can focus their business value creation even better on direct care for people in need of care. In this way, care homes can position themselves as more attractive employers for care staff because they have state-of-the-art digital equipment.With the Care. For the Care. The solution was developed and tested together with the care practice. With the IoT and future-proof platform approach, caregivers will benefit from additional functions in an established and accepted product setting. The system can be connected to various care documentation systems via open interfaces. The aim of the solution is not only to reduce the workload for all those involved in care. Care homes can also optimize teamwork and automate routine processes to support caregivers in the interests of people-centric care in the face of an increasing shortage of skilled staff. With the market entry, care homes can obtain information and order from us or one of our partners. While they order smart Diapers from our partners in the unit price context they are used to, alea Digital System comes as a software-as-a-service model. Without any additional initial costs, they can use all functions via personally provided hardware and software for each care recipient – for the most cost-efficient and needs-orientated use.
Show all investments...

Arda Kara
Angel · San Francisco, California, United States · 1 investments in Switzerland Biotechnology startups

Arda Kara

Show more...

Investment focus

  • Industry: Health Care, Medical, Software
  • Stage:Series A, Seed, Series B
  • Geography: United States, Germany, Switzerland

Investor stats

  • Total investments: 9
  • Round size: Series A $25M–$38M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Human API — Health data platform that connects to all data sources, enabling companies to build new technologies & deliver better experiences to customers.
  • Levels — Improve metabolic health with CGM, comprehensive labs, and a personalized plan.
  • Blackrock Neurotech — Blackrock Neurotech innovative brain technologies provide new hope for people with paralysis & other neurological disorders.
Show all investments...

Konstantin Othmer
Angel · Mountain View, California, United States · 1 investments in Switzerland Biotechnology startups

Konstantin Othmer is the Co Founder & CEO at Speechpad.

Show more...

Investment focus

  • Industry: Automotive, Health Care, SaaS
  • Stage:Seed, Pre-Seed
  • Geography: United States, Latvia, Germany

Investor stats

  • Total investments: 16
  • Round size: Seed $520k–$18M; Pre-Seed $1M–$2.3M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • aiomics — Aiomics | Back to your calling.Across Europe, healthcare providers lose hours every day to fragmented documentation—handwritten notes, scanned PDFs, dictations, disconnected IT systems. The result: burnout, missed revenue, and patients feeling like they’re asked the same question three times.Aiomics changes this. Our AI-driven co-pilot capturesevery clinical detail—speech, handwriting, digital notes—and validates it in real time with a human-in-the-loop process. Interactive checklists surface missing information before the patient leaves, and audit-ready records flow straight back into existing systems. Built for GDPR, MDR, and the EU AI Act from day one, Aiomics makes documentation complete, compliant, and instantly usable.We don’t replace EHRs—we make them better. From admission and discharge reports to insurer forms, from therapist briefings to patient-friendly letters, Aiomics turns paperwork from a burden into an asset. For providers, that means fewer errors, faster reimbursements, and—most importantly—more time at the bedside.Our mission: to empower healthcare professionals by removing administrative burdens and elevating their decision-making with trusted AI guidance—so they can reconnect with why they chose this vocation in the first place.Who we are: Aiomics is co-founded by Dr. Sven Jungmann, a physician with frontline experience of administrative overload; Dr. Nikita Tarasov, a physicist and data scientist; and a lawyer who scaled one of Europe’s largest digital service companies. Together, we unite empathy, technical mastery, and regulatory expertise to build the trusted co-pilot for Europe’s healthcare providers.
  • elasticStage — Create your own vinyl or CD today. Upload music & artwork, order copies, or sell to fans for free with elasticStage. No costs, shipped in weeks not months.
  • YOUTH — Full health check-up in less than 2 minutes!
Show all investments...

Balaji Srinivasan
Angel · San Francisco Bay Area, California, United States · 1 investments in Switzerland Biotechnology startups, 18 in the past 12 months

Balaji S. Srinivasan is the Co-Founder and Board Member of Coin Center. He was the CTO of Coinbase and cofounder of Counsyl, Earn, Teleport, and Coin Center. Dr. Srinivasan holds a BS, MS, and PhD in Electrical Engineering and an MS in Chemical Engineering from Stanford University. He also teaches the occasional class at Stanford, including anonline MOOC.

Show more...

Investment focus

  • Industry: Blockchain, Cryptocurrency, Software
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, India, Singapore

Investor stats

  • Total investments: 276
  • Round size: Seed $2.3M–$15M; Pre-Seed $650k–$4.2M; Series A $6M–$28M
  • Lead/follow: 5% lead, 95% follow

Portfolio highlights

  • Vorflux — Cloud agents that ship production code. An opinionated harness that runs the full SDLC on dedicated machines.
  • Dirac Labs — Universal Navigation Powered by Quantum Sensing & AI
  • Physical Superintelligence — Physical Superintelligence develops physical superintelligence systems that use AI-driven research to study physics, engineer physical systems, and explore new physical laws. Its approach combines human scientists with virtual physicists that conduct autonomous research campaigns covering hypothesis development, verification, experimentation,engineering, and deployment. The company focuses initially on the physical infrastructure underlying AI, including energy, materials, computation, sensing, and manufacturing.
Show all investments...

Helmut Deschauer
Angel · 1 investments in Switzerland Biotechnology startups

Helmut Deschauer is an angel investor.

Show more...

Investment focus

  • Industry: Genetics, Oncology, Generative AI
  • Stage:Pre-Seed
  • Geography: Switzerland

Investor stats

  • Total investments: 2
  • Round size: Pre-Seed $1.5M–$1.9M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • ABSORA — ABSORA is pioneering breakthrough materials that outperform existing solutions in silencing noise and vibration.
  • Qnomx — Reduce expert workload per NGS case by up to 85%. Qnomx leverages AI to streamline NGS interpretation and generate clinician-ready reports.
Show all investments...

Tej Tadi
Angel · San Francisco, California, United States · 1 investments in Switzerland Biotechnology startups

Tej Tadi is an Electronics Engineer and has pursued an advanced master in Virtual Reality & Computer Graphics at The Swiss Federal Institute of Technology (EPFL), Switzerland. During his PhD (EPFL), he set up an immersive virtual reality system in combination with state-of-the-art brain imaging technologies enabling trans-disciplinary work incognitive psychology, neuroimaging, and virtual reality. His research has led to important and highly visible scientific publications (Science) and awards (Pfizer Award for Neuroscience in 2009). Through his research, he has built a strong multi-disciplinary base spanning computer science, systems biology, neuroimaging, and computational and cognitive neuroscience. He founded MindMaze in 2011 to design and develop novel applications in Neuro-Rehabilitation, Game training & Interfaces. The technology platform from MindMaze will help in the neurology, psychiatry and sports rehabilitation.

Show more...

Investment focus

  • Industry: Robotics, Neuroscience
  • Stage:Seed
  • Geography: Switzerland

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Metaphysiks — Metaphysiks is a groundbreaking immersive technology company combining world leading neuroscience and robotics to create multisensory experiences.
Show all investments...

Peter Herger
Angel · Zürich, Zurich, Switzerland · 1 investments in Switzerland Biotechnology startups

Peter Herger is a private investor.

Show more...

Investment focus

  • Industry: Wellness, Neuroscience, Information Technology
  • Stage:Pre-Seed
  • Geography: Switzerland

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • MindMetrix — MindMetrix is a startup project team of ETH Zurich which envisions products that quantify the performance of your mind and mental wellbeing.
Show all investments...

Ian Metcalfe
Angel · 1 investments in Switzerland Biotechnology startups

Ian Metcalfe is an individual investor.

Show more...

Investment focus

  • Industry: Biotechnology
  • Stage:Pre-Seed
  • Geography: Switzerland

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • CellX Biosolutions — CellX Biosolutions harnesses bacteria to sustainably treat chemical waste including PFAS, pharmaceuticals, and microplastics, offering innovative, eco-friendly waste management solutions.
Show all investments...

Zürcher Kantonalbankand
Angel · 1 investments in Switzerland Biotechnology startups

Zürcher Kantonalbankand

Show more...

Investment focus

  • Industry: Medical Device, Energy, Leasing
  • Stage:Seed, Series A, Series B
  • Geography: Switzerland

Investor stats

  • Total investments: 6
  • Round size: Seed $1.1M–$4.4M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Aspivix — ASPIVIX is developing a new generation of medical devices that make gynecological procedures gentler and safer for women and gynecologists. The first device, CAREVIX, is designed to prevent cervix bleeding using a suction technology to replace traumatic tenaculum (forceps).
  • Positrigo — NeuroLF is an ultra-compact brain Positron Emission Tomography system. Our technology makes functional imaging accessible for people worldwide.
  • Spacewise — Find out how to optimize revenue & occupancy, and attract exciting new tenants.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Ronjon Nag
Angel · San Francisco, California, United States · 1 investments in Switzerland Biotechnology startups

Dr. Ronjon Nag is CEO/Co-Founder of Cellmania & R42 Group, a leading wireless applications company. Dr. Nag, is an acknowledged authority in the mobile industry, having been featured on the cover of Fortune and involved in the development of, and holding patents in, wireless applications, user interfaces and new m-commerce distributionmethods of mobile applications and devices. Previously a Vice President and General Manager at Motorola responsible for smart mobile technologies developed in the Lexicus Division and Motorola Human Interface Laboratories worldwide, hundreds of millions of Motorola devices have shipped with technology developed under his leadership - voice recognition, handwriting recognition and predictive text key systems. Previously Dr. Nag was CEO/founder of Lexicus, a pioneer of speech and handwriting recognition technology, acquired by Motorola in 1993. Dr. Nag holds a Ph.D. from Cambridge University (speech recognition research), was a Harkness Fellow at Stanford University (neural network research), has an MBA from MIT, and a 1st class Honours degree of Birmingham University, UK (electrical engineering).

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Health Care
  • Stage:Seed, Pre-Seed, Series B
  • Geography: United Kingdom, United States, Canada

Investor stats

  • Total investments: 14
  • Round size: Seed $1.2M–$13M; Pre-Seed $472k–$2M
  • Lead/follow: 36% lead, 64% follow

Portfolio highlights

  • Introhive — Introhive is a Relationship Intelligence platform that helps firms overcome data silos and unlock actionable relationship insights that drive collaboration and growth.
  • Civil Maps — The Civil Maps sensor-agnostic platform enables high-accuracy, low-cost 3D HD mapping and localization at scale. Auto OEMs, mapping companies, and mobility providers use our technology to advance their autonomous driving initiatives by integrating our localization technology with their decision-making stack and sensor configurations of choice.Civil Maps enables vehicles to develop and leverage their own “mental model” of the world; they can can create, utilize, and create maps with the industry’s most cost-effective, scalable, and robust methods available today. Civil Maps’ proprietary Fingerprint Basemap Technology is at the core of our offerings in sensor fusion, 3D mapping, centimeter-accurate localization at scale. While empowering vehicles with full environmental awareness and enhanced safety, Civil Maps is able to dramatically reduce the cost, compute, and energy requirements involved in continental-scale deployment of delivery bots and autonomous vehicles.
  • Molecule — Molecule is a collaborative platform, where stakeholders in drug development work together to accelerate the process of bringing novel therapeutics to patients. We connect leading researchers to investment opportunities by turning intellectual property and its development into a liquid and easily investable asset.
Show all investments...

Katelyn Donnelly
Angel · New York, New York, United States · 1 investments in Switzerland Biotechnology startups

Katelyn Donnelly is the General Partner at Avalanche VC. She attended Duke University.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Education
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, Germany

Investor stats

  • Total investments: 13
  • Round size: Seed $1.1M–$13M; Pre-Seed $600k–$1.4M
  • Lead/follow: 15% lead, 85% follow

Portfolio highlights

  • Bluesky — Bluesky is a new social media platform.
  • TrustedRouter — TrustedRouter develops an independent API router and intelligent architecture that protects privacy through an attested gateway.
  • Civic Marketplace — Civic Marketplace is a platform that simplifies purchasing decisions, helps agencies make efficient, informed choices, and boosts local economic growth by providing access and opportunities to historically underutilized businesses.
Show all investments...

Ulf Claesson
Angel · 1 investments in Switzerland Biotechnology startups

Ulf Claesson

Show more...

Investment focus

  • Industry: Biotechnology, Food and Beverage
  • Stage:Seed
  • Geography: Switzerland

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • MIRAI FOODS — Love meat? Mirai aims to produce the meat of the future by cultivating animal cells in a controlled environment
Show all investments...

Philip Wels
Angel · 1 investments in Switzerland Biotechnology startups

Philip Wels is an individual investor.

Show more...

Investment focus

  • Industry: Information Technology, Sports, Software
  • Stage:Pre-Seed, Seed
  • Geography: Switzerland

Investor stats

  • Total investments: 3
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Riverkin — Riverkin builds rugged, low-cost water sensor systems for rivers that measure turbidity and temperature in real time. Our platform turns field data into clear insights and decision making tools.
  • BreezeLabs — Most runners track their performance.
  • MindMetrix — MindMetrix is a startup project team of ETH Zurich which envisions products that quantify the performance of your mind and mental wellbeing.
Show all investments...

Feike Sijbesma
Angel · 1 investments in Switzerland Biotechnology startups

Feike has been the CEO and Chairman of the Managing Board of Directors of Royal DSM N.V. (a global Life Sciences and Materials Sciences company) since May 2007. In 1995, Feike became director of Gist-Brocades Food Specialties Division and joined Gist-Brocade’s executive committee. Following the acquisition by Royal DSM N.V. in 1998, he became adirector of the business group DSM Food Specialties. In 2000 he joined Royal DSM’s managing board of directors, becoming Chairman and CEO in May 2007.He is currently a member of the supervisory board of De Nederlandsche Bank (DNB, the Dutch Central Bank), and a board member of CEFIC (European Chemical Industry Council) and member of the Global CEO Council (GCC) of the Chinese People’s Association for Friendship with Foreign Countries (CPAFFC).His previous roles have included member of the Supervisory Board of DSM Netherlands, the Utrecht University, the Dutch Genomics Initiative (NGI) and the Anthonie van Leeuwenhoek Hospital/Netherlands Cancer Institute (NKI/AVL), chairman of Chemical Governors and a Global Agenda Council of the World Economic Forum, Dutch Food Chain Sustainability Foundation (DUVO) and of EuropaBio (European Biotech Association), a member of the Dutch Innovation Platform 2.0, board member of BIO (US Biotechnology Association), the Swiss Society of Chemical Industries (SCGI) and the Dutch Nutrition/Food Top-Institute (WCFS) and a member of the advisory board of ECP-EPN (e-commerce) and the Rotterdam Business School of the Erasmus University.

Show more...

Investment focus

  • Industry: Biotechnology, Bioinformatics, Pharmaceutical
  • Stage:Seed, Series B
  • Geography: Switzerland, United Kingdom

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Cradle — Using robust prediction algorithms and AI design recommendations, Cradle assists biologists in rapidly designing better proteins. Cradle gives you complete ownership of the intellectual property while maintaining the privacy and security of your sequences and data.
  • Basecamp Research — Novel proteins from nature. We sample the most extreme and exciting places on the planet to build the world's largest knowledge graph of natural biodiversity.
Show all investments...

Piero Novelli
Angel · 1 investments in Switzerland Biotechnology startups

Piero Novelli is the Chairman-Supervisory Board at Euronext NV.

Show more...

Investment focus

  • Industry: Wellness, Neuroscience, Information Technology
  • Stage:Pre-Seed
  • Geography: Switzerland

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • MindMetrix — MindMetrix is a startup project team of ETH Zurich which envisions products that quantify the performance of your mind and mental wellbeing.
Show all investments...

Urs Berger
Angel · Basel, Basel-Stadt, Switzerland · 1 investments in Switzerland Biotechnology startups

Urs Berger is the current President of Swiss Entrepreneurs Foundation. He previously worked at JAROWA AG as a Chairman of the Board. Urs Berger attended Northwestern University - Kellogg School of Management.

Show more...

Investment focus

  • Industry: Wellness, Neuroscience, Information Technology
  • Stage:Pre-Seed
  • Geography: Switzerland

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • MindMetrix — MindMetrix is a startup project team of ETH Zurich which envisions products that quantify the performance of your mind and mental wellbeing.
Show all investments...

John Zimmer
Angel · San Francisco Bay Area, California, United States · 1 investments in Switzerland Biotechnology startups

John Zimmer is based out of San Francisco Bay Area, California and was the Vice Chair of the Board of Directors of Lyft. John Zimmer attended the Cornell University.

Show more...

Investment focus

  • Industry: Mining, FinTech, Mineral
  • Stage:Seed, Series B
  • Geography: United States, Denmark, Switzerland

Investor stats

  • Total investments: 4
  • Round size: Seed $5M–$5.7M; Series B $30M–$193M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Jabbr — Jabbr allows to capture boxing matches with a virtual video production.Its goal is to make video production and advanced performance analytics in combat sports available to anyone with a smartphone.
  • Cradle — Using robust prediction algorithms and AI design recommendations, Cradle assists biologists in rapidly designing better proteins. Cradle gives you complete ownership of the intellectual property while maintaining the privacy and security of your sequences and data.
  • KoBold Metals — Finding the materials of the future with AI and HI
Show all investments...

Thorsten Schroeder
Angel · 1 investments in Switzerland Biotechnology startups

Thorsten Schroeder

Show more...

Investment focus

  • Industry: Children, E-Commerce, Electronics
  • Stage:Seed, Series B, Venture - Series Unknown
  • Geography: United States, Brazil, Mexico

Investor stats

  • Total investments: 11
  • Round size: Seed $4M–$15M; Series B $18M–$23M; Venture - Series Unknown $5.8M–$15M
  • Lead/follow: 18% lead, 82% follow

Portfolio highlights

  • Storypod — The screen-free, educational audio toy that engages children independently & makes learning fun. Storypod delights toddlers, preschoolers, 1st, & 2nd graders with music, stories, songs, audiobooks, & podcasts. The Storypod audio player features recording from any phone, bedtime nightlight, sound machine, & white noise.
  • TROCAFONE — Trocafone is the first end-to-end e-commerce marketplace of LATAM that enable people to buy and sell used electronics hassle free, focused on smartphones in Brazil. At Trocafone they improve the selling and buying experience by acquiring the devices from sellers, refurbishing and re-selling them as pre-owned certified. Buyers enjoy the greatdeals of a peer-to-peer marketplace combined with the service, convenience, and safety of a retail store. Sellers enjoy a streamlined experience since It takes seconds to sell an item, and shipping is effortless with Trocafone's pre-addressed, pre-stamped mailers.
  • 4D Lifetec — 4D Lifetec is a biotechnology company promoting and developing screening and test systems for molecular diagnostics. It also offers a unique solution for DNA defect and repair based screening programs and is, therefore, the diagnostic method of the first choice. The company profits from different networks in science and healthcare.4D Lifetecprovides kits, reagents, download center, 4D life tanks, and service packages. They also offer cost savings for healthcare provider by its outstanding precision and a high degree of standardization both leading to a reduction of false positive results.4D Lifetec was founded by Dr. Arne Faisst and Nick Mijnssen in 2014 and is headquartered in Cham, Zug.
Show all investments...

Walter Fischl
Angel · 1 investments in Switzerland Biotechnology startups

Walter Fischl

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Venture - Series Unknown
  • Geography: Switzerland

Investor stats

  • Total investments: 1
  • Lead/follow: 100% lead, 0% follow

Portfolio highlights

  • Proteomedix — ProteoMediX is a spinoff company of ETH Zurich and specialized in the identification of novel biomarkers for the early detection of cancer and the personalized treatment thereof.The first product currently developed is a blood-based test that enables the diagnosis of prostate cancer with significantly higher accuracy than today's clinicalstandard.This reduces unnecessary biopsies and thus results in significant cost savings for the healthcare system and less discomfort for the patient.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Nitin Sharma
Angel · Bangalore, Karnataka, India · 1 investments in Switzerland Biotechnology startups

For the last 10+ years, I've had the rare fortune of working with world-class entrepreneurs - as a venture or angel investor, startup team member or growth advisor - in the US and in India. Experience: US VC - Investor @ NEA India VC - Principal & Founding Member @ Lightbox (ex. Kleiner Perkins India and Sherpalo) Startup ops in the US- VP, Bus Dev and early employee @ EverFi (one of the largest edtech networks globally) Startup ops in India - Key leadership responsibilities related to 4 Lightbox companiesCurrently, I am especially spending a large portion of my time on blockchain startups and cryptocurrencies. INVESTING: Lots of learnings from working on early to growth stage investments. US: Millennial Media (IPO, acq. by AOL), OPOWER (IPO, acq. by Oracle), Gilt Groupe (acq. by Saks / Hudson Bay), ChannelAdvisor (IPO), AddThis (acq. by Oracle), EverFi, Suniva, Videology, Credibase, new crypto and blockchain projects India: Droom, Melorra, Paymate, Zoomin, Stalkbuylove, Fynd, The Better India, Mech MochaSTARTUP OPERATIONS: Hands-on experience in both hyper-growth and turnaround situations. Wore a few hats as an early employee and head of BD at EverFi (one of the largest edtech networks globally having served 16MM students and raised $250MM), led strategic finance projects for NEA companies Suniva and AddThis, and interned at InMobi. Owned or helped solve problems across strategy, M&A, senior hiring, int'l expansion and fundraising while working closely with management at Droom, Melorra, Paymate and Zoomin

Show more...

Investment focus

  • Industry: Financial Services, Software, Information Technology
  • Stage:Pre-Seed, Seed, Grant
  • Geography: India, United States, Germany

Investor stats

  • Total investments: 46
  • Round size: Seed $572k–$11M; Pre-Seed $165k–$2M
  • Lead/follow: 72% lead, 28% follow

Portfolio highlights

  • Klub — India's leading Revenue Based Financing platform with a vision to revolutionize growth capital. Join the Klub for fast, fair & flexible funding.
  • StayQrious — StayQrious is an ed-tech startup that focuses on skilling students in computer applications such as coding through online group classes. The company also focuses on collaboration, critical thinking, and creativity through these virtual classrooms.
  • Molecule — Molecule is a collaborative platform, where stakeholders in drug development work together to accelerate the process of bringing novel therapeutics to patients. We connect leading researchers to investment opportunities by turning intellectual property and its development into a liquid and easily investable asset.
Show all investments...

Young Sohn
Angel · San Francisco, California, United States · 1 investments in Switzerland Biotechnology startups

Young Sohn is a Silicon Valley entrepreneur whose passion is building businesses and fostering emerging technologies that have the potential to transform the world for the better. Currently, Sohn serves as Corporate President and Chief Strategy Officer of Samsung Electronics and Chairman of the Board of HARMAN. He leads Samsung’s strategy forglobal innovation, investment, and new business creation, and led the company’s $8 billion acquisition of HARMAN. Prior to joining Samsung Electronics, Sohn served as CEO of two successful, public Silicon Valley companies and on the boards of Arm, Cadence, Cymer (ASML), and others. Under his leadership as CEO and board member, he took PLX Technologies, Synnex Technologies, and Inphi public. He was also a seed investor in some of the industry’s most innovative companies, including Bitfury, Fungible, Graphcore, and Zoom.Sohn is a leader of the global Tech for Good movement. He helped launch the Extreme Tech Challenge (XTC), the world’s largest startup competition for entrepreneurs addressing global challenges. He also serves as a North America board member at MIT Sloan, a senior advisor to the private equity firm Silver Lake Partners, a board member at Cadence, and an advisor for the University of California Innovation Council. Sohn holds a BS in electrical engineering from the University of Pennsylvania and an MS from the MIT Sloan School of Management. An avid outdoorsman, Sohn spends his personal time kite surfing, cycling, running, hiking, and competing in triathlons.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, SaaS
  • Stage:Seed, Series A, Series B
  • Geography: United States, Germany, Switzerland

Investor stats

  • Total investments: 25
  • Round size: Seed $200k–$18M; Series A $20M–$80M; Series B $24M–$110M
  • Lead/follow: 28% lead, 72% follow

Portfolio highlights

  • Revolear — Revolutionize your dealmaking with Revolear, the end-to-end platform for structuring, proposing, negotiating, and approving deals. Designed for Humans. Powered by AI.
  • Unique AI — Unlock the power of generative AI in Finance with Unique FinanceGPT. Get custom use cases and accurate insights in a secure, enterprise-ready platform.
  • Perfect — A personalized talent-finding and engaging experience made for every team.
Show all investments...

Kirill Eves
Angel · 1 investments in Switzerland Biotechnology startups

Kirill Eves is a visionary serial entrepreneur and founder with a proven track record of building successful profound fintech companies for the past 15 years.

Show more...

Investment focus

  • Industry: B2B, Gaming, Medical
  • Stage:Seed, Pre-Seed
  • Geography: India, Switzerland, United Arab Emirates

Investor stats

  • Total investments: 3
  • Round size: Seed $3M–$18M
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • LIOM — Pioneering in non-invasive glucose monitoring technology, seamlessly integrated with health metrics for a revolutionary wearable experience.
  • Paytring — Enable merchants, PSPs, and banks to run multi-currency, multi-region payments through a single unified rail. 50+ PSP integrations, 100+ payment methods, global coverage.
  • Playgama — Playgama is a fast-growing distributor of HTML5 games, connecting developers to an audience of 220 million monthly active players. We simplify game distribution and monetization, allowing developers to focus on creating exceptional games while we handle the rest. With open-source SDK, games distributed thought Playgama can reach players acrossleading high-traffic platforms, ensuring global exposure—from Europe to Asia and USA.
Show all investments...

Edward Ludwig
Angel · Demarest, New Jersey, United States · 1 investments in Switzerland Biotechnology startups

Edward Ludwig has been a Member of the Board of Directors of Boston Scientific since March 2014. Edward is the former Chairman of the Board of Directors of Becton, Dickinson and Company (“BDX”), a global medical technology company, having served in that position from February 2002 through June 2012. Edward also served as BDX’s ChiefExecutive Officer from January 2000 to September 2011 and as its President from May 1999 to December 2008. Edward joined BDX as a Senior Financial Analyst in 1979. Prior to joining BDX, Edward served as a Senior Auditor with Coopers and Lybrand (now PricewaterhouseCoopers) where he earned his CPA and as a financial and strategic analyst at Kidde, Inc. Edward serves as Lead Director on Aetna Inc.’s Board of Directors and chairs its Finance Committee and is a Member of the Board of Directors of Xylem, Inc. Edward serves as the Non-Executive Chairman of POCARED, a privately held firm in Israel. Edward is also a Member of the Board of The Center for Higher Ambition Leadership, which is dedicated to studying, documenting and advancing the principals of Higher Ambition Leadership that drive the most successful enterprises in terms of longer term shared value creation. Edward served as a Member of the Board of Trustees of the College of the Holy Cross (2005-2013), and the Columbia Business School Board of Overseers (2010-2015). Edward also served as a Member of the Board of Trustees of the Hackensack University Medical Center Network Board of Trustees. Edward received a B.A. degree in Economics and Accounting from The College of the Holy Cross and a MBA degree from Columbia University.

Show more...

Investment focus

  • Industry: Medical, Biotechnology, Health Care
  • Stage:Seed, Series A, Corporate Round
  • Geography: Switzerland, United States

Investor stats

  • Total investments: 4
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • LIOM
  • LIOM — Pioneering in non-invasive glucose monitoring technology, seamlessly integrated with health metrics for a revolutionary wearable experience.
  • Velano Vascular — Establishing a new standard of care for inpatient blood draws by improving the experience and reducing pain, risks and inefficiencies of existing practices.
Show all investments...

Qiao Wang
Angel · Manhattan, New York, United States · 1 investments in Switzerland Biotechnology startups

Qiao Wang is a believer in decentralized technologies such as cryptocurrencies that shift the balance of power from the elite to the commoner.

Show more...

Investment focus

  • Industry: Blockchain, Software, Cryptocurrency
  • Stage:Seed, Pre-Seed, Venture - Series Unknown
  • Geography: United States, Singapore, China

Investor stats

  • Total investments: 32
  • Round size: Seed $1.1M–$12M; Pre-Seed $350k–$3M
  • Lead/follow: 41% lead, 59% follow

Portfolio highlights

  • AltLayer — AltLayer is a system of highly scalable application-dedicated execution layers that derive security from an underlying L1/L2.
  • NEBRA Labs — NEBRA Labs is a blockchain services company.
  • Slide — Slide.so is a premium domain name listed for sale. Secure escrow transfer and lease-to-own options available.
Show all investments...

Christopher Gibson
Angel · Salt Lake City, Utah, United States · 1 investments in Switzerland Biotechnology startups

Christopher Gibson is based out of Salt Lake City, Utah, and is the Interim Executive Advisor, Co-Founder and Chairman of the Board of Directors of Recursion Pharmaceuticals. Christopher previously worked at Cure Hereditary Hemorrhagic Telangiectasia as a Member of the Board of Directors. Christopher Gibson attended the University of Utah.Christopher Gibson has been awarded the 2013 TEDMED Front Line Scholar.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Series A, Seed, Series B
  • Geography: United States, United Kingdom, France

Investor stats

  • Total investments: 28
  • Round size: Seed $1.5M–$14M; Series A $10M–$55M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Zanskar — Zanskar Geothermal & Minerals uses custom AI tools and geoscience models to analyze vast amounts of data and pinpoint untapped geothermal hotspots.
  • Play Health — Delivering data & AI-driven (peri)menopause care software to improve outcomes today, developing precision medicine infrastructure for tomorrow.
  • Dunia Innovation — Catalysing the energy transition.
Show all investments...

Marc Maurer
Angel · Zürich, Zurich, Switzerland · 1 investments in Switzerland Biotechnology startups

Marc Maurer is based out of Zürich, Zurich and is the Board member of Liom. Marc previously worked at On as a Co-CEO. Marc Maurer attended the Zurich University of Applied Sciences/ZHAW.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Machine Learning
  • Stage:Series A
  • Geography: Switzerland

Investor stats

  • Total investments: 2
  • Round size: Series A $16M–$18M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • LIOM — Pioneering in non-invasive glucose monitoring technology, seamlessly integrated with health metrics for a revolutionary wearable experience.
  • Cerrion — Cerrion is a visual AI that helps production teams react faster to process deviations, automate root cause analysis, and implement targeted improvement actions. They believe that process transparency enabled by AI and computer vision is key to achieving more autonomy and sustainability in manufacturing. Their software is built and designed withproduction teams from all over the world in the loop.
Show all investments...

Emily Leproust
Angel · San Francisco, California, United States · 1 investments in Switzerland Biotechnology startups

As an early pioneer in long DNA synthesis, Emily is poised to accelerate the biofactory market. She and co-founder Bill Peck share the world record for synthesizing the longest, highest quality oligo library. Emily architected the successful SureSelect product line which lowered the cost of sequencing and elucidated dozens of mendelian diseases,and she developed Agilent’s Oligo Library Synthesis technology. Emily has co-authored over 34 peer-reviewed papers—many on synthetic DNA—and has extensive marketing, management, and business development experience. Prior to Twist Bioscience, Emily was Director of Applications and Chemistry R&D—Genomics at Agilent Technologies.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Product Research
  • Stage:Seed
  • Geography: United States, Switzerland

Investor stats

  • Total investments: 3
  • Round size: Seed $1.5M–$5.7M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Biostate AI — Biostate AI develops generative AI that benefit all human health.
  • Cradle — Using robust prediction algorithms and AI design recommendations, Cradle assists biologists in rapidly designing better proteins. Cradle gives you complete ownership of the intellectual property while maintaining the privacy and security of your sequences and data.
  • Kiwi Biosciences — Kiwi biosciences is a biotech company that develops enzymes to make food for patients who suffer from Irritable Bowel Syndrome (IBS). The company was founded in 2020 and is based in Somerville, Massachusetts, United States.
Show all investments...

Patrick Delarive
Angel · Lausanne, Vaud, Switzerland · 1 investments in Switzerland Biotechnology startups

Patrick is a businessman active in real estate, wealth management, show business, hospitality, education and private equity, benefiting from a strong network. At Biowatch since November 2015.

Show more...

Investment focus

  • Industry: Security, Wireless, Wearables
  • Stage:Seed
  • Geography: Switzerland

Investor stats

  • Total investments: 1
  • Lead/follow: 100% lead, 0% follow

Portfolio highlights

  • Biowatch — Biowatch is a user-friendly wrist veins biometric reader that functions as a security solution for mobile payment protection and smart device interaction. Users can access the app for enrolling their vein pattern and selecting applications and devices that needs to be connected to their Biowatch, wear their BioWatch and activate it by matchingtheir vein pattern with their enrolled reference, get PKI encrypted user code transmitted from their Biowatch, and start opening doors without the use of keys and passwords.Biowatch was launched by Joe Rice and Matthias Vanoni and is headquartered in Lausanne, Switzerland.
Show all investments...

Reinhard Ambros
Angel · Basel, Basel-Stadt, Switzerland · 1 investments in Switzerland Biotechnology startups

Reinhard Ambros

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Biopharma
  • Stage:Series A, Series B, Series C
  • Geography: United States, Switzerland

Investor stats

  • Total investments: 17
  • Lead/follow: 12% lead, 88% follow

Portfolio highlights

  • Rein Therapeutics — Rein Therapeutics is advancing a novel pipeline of first-in-class medicines to address unmet medical needs in orphan pulmonary and fibrosis indications.
  • Aileron Therapeutics — Aileron Therapeutics - ALRN-6924 - myelopreservation
  • ImmunOs Therapeutics — ImmunOs Therapeutics AG is a clinical-stage biotechnology company focused on discovering and developing next generation and novel human immunomodulatory proteins with a role in both innate and adaptive immunity.Their mission is to develop the next generation of novel therapeutics that will improve the lives of patients with serious disease.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Nicolas Weber
Angel · Berlin, Berlin, Germany · 1 investments in Switzerland Biotechnology startups

Healthcare has been my passion throughout most of my professional life – in international corporate environments and as entrepreneur and Business Angel. I co-founded medneo (https://www.medneo.com/) (Radiology as a Service) and OpenRad (https://www.openrad.com/) (IT rails for diagnostic imaging) and helped to buildit from zero to 550+ people – what a journey. I recently transitioned from Group CEO to the supervisory board. With medneo (https://www.medneo.com/) we are improving access to high-end diagnostic imaging (e.g. MRI, CT, etc.) for patients with a new pan-European operating model for medical service providers: Radiology as a Service. And with OpenRad (https://www.openrad.com/) we bring workflow IT to 3rd party diagnostic centers beyond medneo. I have developed the organization for CEOs to manage the brands independently and I support them actively as board director. Together with my two co-founders André Glardon (https://www.linkedin.com/in/andreglardon/) and Matthias Issing (https://www.linkedin.com/in/matthias-issing/) we – 3minds (https://www.linkedin.com/company/3minds-projects/) – are supporting outstanding impact entrepreneurs on their journey to improve our lives - as angels, mentors and in board functions. We engage directly and via amazing networks like Better Ventures (https://www.betterventures.io/) and Springboard Health (https://www.springboardangels.com/). I'm a grateful member of the Entrepreneurs' Organization (https://eonetwork.org) - the meaningful connections with diverse and inspiring people helped me to grow as a person. Also, I'm a board member of EO's Berlin Chapter (https://www.eoberlin.com/). Berlin (https://goo.gl/maps/6zP6kaWtrY7VQhvu6) based. Originally from the south of Germany (Pforzheim), had the opportunity to live and work abroad (e.g. USA, UK, China). I like endurance sports, especially long-distance running (Marathon+) and cycling. I'm happy to contribute and connect (https://about.me/nicolas.weber) - feel free to reach out! https://www.linkedin.com/in/nicolasweber/

Show more...

Investment focus

  • Industry: Genetics, Oncology, Health Care
  • Stage:Seed, Pre-Seed
  • Geography: Switzerland, United Kingdom

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Sanome — Sanome are combining different types of biomarkers to develop engaging, useful and accurate diagnostic products (IVDs) that enable early detection and prevention of disease. The IVD innovation engine, will ultimately enable new approaches for healthcare delivery, providing access to novel at-home testing paradigms for all people.
  • Qnomx — Reduce expert workload per NGS case by up to 85%. Qnomx leverages AI to streamline NGS interpretation and generate clinician-ready reports.
Show all investments...

Thomas Glocer
Angel · New York, New York, United States · 1 investments in Switzerland Biotechnology startups

Thomas Glocer is based out of New York, New York, and is the Co-Founder and Vice Chairman of the Board at BlueVoyant. Thomas previously worked at Thomson Reuters as a CEO. Thomas Glocer attended Yale Law School.

Show more...

Investment focus

  • Industry: Software, FinTech, Analytics
  • Stage:Seed, Series A, Series C
  • Geography: United States, United Kingdom, Israel

Investor stats

  • Total investments: 56
  • Round size: Seed $1M–$7.7M; Series A $5M–$24M; Series C $13M–$75M
  • Lead/follow: 4% lead, 96% follow

Portfolio highlights

  • Superlegal — Superlegal is an AI Law Firm for Builders. Get your contracts reviewed and redlined by AI and commercial attorneys. Contract Review - Built Like Software, Practiced Like Law.
  • Cradle — Using robust prediction algorithms and AI design recommendations, Cradle assists biologists in rapidly designing better proteins. Cradle gives you complete ownership of the intellectual property while maintaining the privacy and security of your sequences and data.
  • Black Ore Technologies — Black Ore's Tax Autopilot is the first AI tax platform for CPAs, offering complete 1040 tax preparation automation to tax professionals, so they can focus on growing their firm.
Show all investments...

Lukas Speiser
Angel · Zürich, Zurich, Switzerland · 1 investments in Switzerland Biotechnology startups

Lukas Speiser is the founder and CEO of Amorana.ch

Show more...

Investment focus

  • Industry: Health Care, SaaS, Retail
  • Stage:Seed, Pre-Seed
  • Geography: Switzerland, Germany

Investor stats

  • Total investments: 8
  • Round size: Seed $161k–$3M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Dunatura — Dunatura engages in the manufacture and supply of vitamins and micronutrients.
  • Cleveron — Cleveron is an innovative Swiss start up company that has developed an intelligent system for radiator heating systems. With Cleveron, the room temperature in each individual room of a building can be individually and optimally controlled. This can save costs and energy. Simple Home's technology makes an active contribution to reducing CO 2emissions.They have the vision to make part of the big, public buildings in Switzerland and Europe, such as school buildings and administrative buildings, more environmentally friendly. To make this happen, they want to convince cities and communities to convert their buildings to Cleveron technology as quickly as possible. Because with the conversion they are now making a concrete contribution to the rescue of the climate.
  • NextBusiness — NextBusiness makes tools for founders in Switzerland. We build the AI-first business software infinity.swiss.
Show all investments...

Tobias Reichmuth
Angel · Zürich, Zurich, Switzerland · 1 investments in Switzerland Biotechnology startups

Tobias Reichmuth - Founding Partner at Maximon - The Longevity Company Builder @ Maximon

Show more...

Investment focus

  • Industry: E-Commerce, Travel, Internet
  • Stage:Seed, Angel, Pre-Seed
  • Geography: Switzerland

Investor stats

  • Total investments: 8
  • Round size: Seed $327k–$2.6M; Angel $138k–$1.5M
  • Lead/follow: 25% lead, 75% follow

Portfolio highlights

  • Firstcar — Firstcar provides car driving learning assistant services. They offer services that include hand-picked driving schools, student cars with double pedals for rent before and for the driving test, entry-level vehicles that are inexpensive to buy and maintain, support and advice on vehicle purchase, and selected insurances with special rates.
  • MyFeld.ch — Das Geldspielgesetz 2019 regelt legale Online-Casinos in der Schweiz. Was du als Konsument wissen musst: Konzessionen, Steuern, Schutz und deine Rechte.
  • Testmate Health — 2 in 1 urine test with immediate results for Chlamydia trachomatis and Neisseria gonorrhoeae. Results within minutes & 100% anonymous.
Show all investments...

Beat Schillig
Angel · Schlieren, Zurich, Switzerland · 1 investments in Switzerland Biotechnology startups

Beat Schillig is based out of Schlieren, Zurich and is the Co-Managing Director of Venture Kick. Beat previously worked at Coople Switzerland as a Board Member & Angel Investor. Beat attended the University of St. Gallen. Beat Schillig has been awarded Business Angel of the Year 2012.

Show more...

Investment focus

  • Industry: Information Technology, SaaS, Music
  • Stage:Seed, Series A
  • Geography: Switzerland

Investor stats

  • Total investments: 3
  • Round size: Seed $2M–$4.8M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • TYXIT — TYXIT is linking musicians wirelessly without configuration, allowing a personal audio monitoring.
  • PXL Vision — PXL Vision enables state-of-the-art digital identity verification. PXL Vision's highly flexible technology solution helps global customers build trust digitally...
  • 1Drop Diagnostics — 1Drop Diagnostics is a cutting edge medical diagnostics and life science company. They combine the best techniques from microfluidics, biochemistry, photonics and information technology to build high performance point-of-care diagnostics devices.Their vision is to provide high quality medical information for everyone. They aim to increase accessto quality healthcare by providing laboratory quality, easy to use, medical diagnostics in any setting. The 1Drop Diagnostics system is being developed for a broad menu of clinical applications including multiplexed assays of proteins, nucleic acids and peptides. Their first clinical applications are in the screening, diagnostics and monitoring of cardiovascular disease and infectious disease.Their mission is to improve patient lives by enabling precision medicine through non-invasive diagnostic tests providing actionable health information that is accessible to everyone at any time. They facilitate the early detection, prevention and management of disease. They empower people to live better lives.
Show all investments...

Christoph Behn
Angel · Hamburg, Hamburg, Germany · 1 investments in Switzerland Biotechnology startups

Christoph Behn is the Chairman & Founder of better ventures. He previously worked at Die Kartenmacherei as an Advisory Board & Founder. Christoph Behn attended HHL Leipzig Graduate School of Management.

Show more...

Investment focus

  • Industry: Software, Manufacturing, Advanced Materials
  • Stage:Pre-Seed, Seed, Venture - Series Unknown
  • Geography: Germany, Switzerland

Investor stats

  • Total investments: 13
  • Round size: Seed $2.1M–$6.9M; Pre-Seed $1.1M–$1.9M
  • Lead/follow: 8% lead, 92% follow

Portfolio highlights

  • 42watt — 42watt is the first retrofit marketplace for homeowners. The platform streamlines the home retrofit journey by connecting homeowners with tailored, end-to-end solutions across solar, heating, mobility, and electricity. Fully digital and manufacturer-independent, 42watt designs optimal systems, matches projects with vetted local installers, andensures real-time optimization. By handling the complexity, 42watt empowers installers to focus on delivering high-quality work.
  • Strollme — Strollme believes in idea of using resources wisely, they started with stroller which can be reused for next time.
  • Qnomx — Reduce expert workload per NGS case by up to 85%. Qnomx leverages AI to streamline NGS interpretation and generate clinician-ready reports.
Show all investments...

Marcello Campanelli
Angel · 1 investments in Switzerland Biotechnology startups

Marcello Campanelli is a general manager at Parker Lord.

Show more...

Investment focus

  • Industry: Biotechnology
  • Stage:Pre-Seed
  • Geography: Switzerland

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • CellX Biosolutions — CellX Biosolutions harnesses bacteria to sustainably treat chemical waste including PFAS, pharmaceuticals, and microplastics, offering innovative, eco-friendly waste management solutions.
Show all investments...

Miklos Stanek
Angel · Zürich, Zurich, Switzerland · 1 investments in Switzerland Biotechnology startups

Miklos Stanek joined BackBone Ventures as Founding Partner & Chairman.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Pharmaceutical
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Switzerland

Investor stats

  • Total investments: 6
  • Round size: Series A $5.1M–$7.7M
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • Neon — With neon, you can pay, save and manage your money. Digitally, securely and with no hidden fees. Open your account online in less than 10 minutes!
  • ImmunOs Therapeutics — ImmunOs Therapeutics AG is a clinical-stage biotechnology company focused on discovering and developing next generation and novel human immunomodulatory proteins with a role in both innate and adaptive immunity.Their mission is to develop the next generation of novel therapeutics that will improve the lives of patients with serious disease.
Show all investments...

Mathias Maurer
Angel · Zürich, Zurich, Switzerland · 1 investments in Switzerland Biotechnology startups

Mathias Maurer

Show more...

Investment focus

  • Industry: Wellness, Neuroscience, Information Technology
  • Stage:Seed, Pre-Seed
  • Geography: Switzerland

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Riverkin — Riverkin builds rugged, low-cost water sensor systems for rivers that measure turbidity and temperature in real time. Our platform turns field data into clear insights and decision making tools.
  • MindMetrix — MindMetrix is a startup project team of ETH Zurich which envisions products that quantify the performance of your mind and mental wellbeing.
Show all investments...

Delia Schrafl
Angel · 1 investments in Switzerland Biotechnology startups

Delia Schrafl serves as an Advisor to the Investment Committee of Evoleen Invest AG.

Show more...

Investment focus

  • Industry: Wellness, Neuroscience, Information Technology
  • Stage:Pre-Seed
  • Geography: Switzerland

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • MindMetrix — MindMetrix is a startup project team of ETH Zurich which envisions products that quantify the performance of your mind and mental wellbeing.
Show all investments...

Biotechnology Angel investor funding in Switzerland at a glance

Stats across 33 deals from 49 investors.

49
investors
in Switzerland Biotechnology startups
33
deals
in Switzerland Biotechnology startups
$8M
median round
in Switzerland Biotechnology startups
12%
lead investors
lead at least one round
30%
Seed
most common funding stage

Access all 49 angel investors in Switzerland Biotechnology startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Biotechnology Angel Investors in Switzerland investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 49 angel investors investing in Switzerland Biotechnology startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists